Patents by Inventor Bernhard Streuff

Bernhard Streuff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Effervescent composition and tablet made there from
    Patent number: 5762951
    Abstract: The present invention relates to an acidic effervescent component for direct tableting of effervescent tablets and a process for its preparation.
    Type: Grant
    Filed: July 26, 1993
    Date of Patent: June 9, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Joachim Maasz, Christian Fritsch, Werner Grawingholt, Bernhard Streuff, Georg Frank
  • Preparation of solid medicament formulation containing nitrendipine
    Patent number: 4724141
    Abstract: A solid medicament formulation comprising 1 part by weight of crystalline nitrendipine, 0.5-1 part by weight of polyvinylpyrrolidone, 0.05-0.5 part by weight of sodium lauryl-sulphate, 1-6 parts by weight of corn starch, 0.5-4 parts by weight of microcrystalline cellulose, 0-5 parts by weight of lactose and 0.01-0.05 parts by weight of magnesium stearate. Such small size formulation has a high bioavailability.
    Type: Grant
    Filed: September 5, 1985
    Date of Patent: February 9, 1988
    Assignee: Bayer Aktiengesellschaft
    Inventors: Wolfgang Schmidt, Bernhard Streuff, Manfred Winter
  • Complexes of prostaglandins
    Patent number: 4675182
    Abstract: The present invention relates to complexes of prostaglandins and crosspovidone, pre-pasted starch or dextrans, a process for the preparation of these complexes, their use in or as medicaments, and medicaments or pharmaceutical formulations containing complexes of prostaglandins or crosspovidone, pre-pasted starch or dextrans.
    Type: Grant
    Filed: January 27, 1984
    Date of Patent: June 23, 1987
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bernhard Streuff, Detlef Mathes, Bernd Schade, Ulrich Schorsch
  • Delayed-action acetylsalicylic acid formulations for oral administration
    Patent number: 4601895
    Abstract: A delayed-action acetylsalicylic acid formulation comprising by weight 60 to 90% of acetylsalicylic acid, 8 to 40% pregelatinized starch, and 0 to 30% of additives. The amount of starch controls the rate of release.
    Type: Grant
    Filed: December 6, 1984
    Date of Patent: July 22, 1986
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bernhard Streuff, Johann Putter, deceased